Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate. - Suppr | 超能文献

Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate.

作者信息

Robinson M R

机构信息

Pontefract General Infirmary, West Yorkshire, England, U.K.

出版信息

Prog Clin Biol Res. 1987;243A:383-90.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate.

Prog Clin Biol Res. 1987;243A:383-90.

2

EORTC protocol 30805: a phase III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.

Prog Clin Biol Res. 1988;260:101-10.

3

The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group phase III clinical trial (protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.

Eur Urol. 1995;28(4):273-83.

4

Cyproterone acetate versus medroxyprogesterone acetate versus diethylstilbestrol in the treatment of prostate cancer: results from EORTC Study 30761.

Prog Clin Biol Res. 1987;243A:379-82.

5

EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group.

Prog Clin Biol Res. 1989;303:111-6.

6

Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.

Am J Clin Oncol. 1988;11 Suppl 1:S33-5.

7

Management of metastatic prostatic carcinoma.

Drug Ther Bull. 1986 Nov 3;24(22):85-8.

8

Use of cyproterone acetate in prostate cancer.

Urol Clin North Am. 1991 Feb;18(1):111-22.

9

[Treatment of prostatic cancer: medroxyprogesterone acetate, diethylstilbestrol and cyproterone acetate. Provisional report of a random study by the genito-urinary cooperative group of the EORTC].

Arch Esp Urol. 1982 Sep-Oct;35(5):304-11.

10

[Cyproterone acetate and cancer of the prostate. Experience in 46 cases].

Therapie. 1988 May;43(3):175-7.

引用本文的文献

1

Maximal androgen blockade for advanced prostate cancer.

Cochrane Database Syst Rev. 2000;1999(2):CD001526. doi: 10.1002/14651858.CD001526.